11. Efficacy and safety of dupilumab in atopic dermatitis in elderly patients: a retrospective study. (24th May 2020) Authors: Napolitano, M.; Fabbrocini, G.; Scalvenzi, M.; Blasio, C.; Stingeni, L.; Patruno, C. Journal: Clinical and experimental dermatology Issue: Volume 45:Number 7(2020) Page Start: 888 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Expression of FK506‐binding protein 51 (FKBP51) in Mycosis fungoides. (9th November 2017) Authors: Mascolo, M.; Romano, M.F.; Ilardi, G.; Romano, S.; Baldo, A.; Scalvenzi, M.; Argenziano, G.; Merolla, F.; Russo, D.; Varricchio, S.; Pagliuca, F.; Russo, M.; Ciancia, G.; De Rosa, G.; Staibano, S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 5(2018) Page Start: 735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Increased expression of interleukin‐23A in lesional skin of patients with atopic dermatitis with psoriasiform reaction during dupilumab treatment. (15th September 2020) Authors: Napolitano, M.; Caiazzo, G.; Fabbrocini, G.; Balato, A.; Di Caprio, R.; Scala, E.; Scalvenzi, M.; Patruno, C. Journal: British journal of dermatology Issue: Volume 184:Number 2(2021) Page Start: 341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Increased expression of interleukin‐23A in lesional skin of patients with atopic dermatitis with psoriasiform reaction during dupilumab treatment. (1st February 2021) Authors: Napolitano, M.; Caiazzo, G.; Fabbrocini, G.; Balato, A.; Di Caprio, R.; Scala, E.; Scalvenzi, M.; Patruno, C. Journal: British journal of dermatology Issue: Volume 184:Number 2(2021) Page Start: 341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Nail changes as manifestation of systemic disease in COVID‐19 infection. (28th April 2021) Authors: Ocampo‐Garza, S.S.; Ocampo‐Candiani, J.; Camela, E.; Vastarella, M.; Fabbrocini, G.; Scalvenzi, M.; Villani, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 8(2021) Page Start: e474 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Psoriasis and sport: a new ally?. (30th July 2014) Authors: Balato, N.; Megna, M.; Palmisano, F.; Patruno, C.; Napolitano, M.; Scalvenzi, M.; Ayala, F. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 3(2015:Mar.) Page Start: 515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Reply to 'A case of dystrophic epidermolysis bullosa pruriginosa treated with dupilumab' by Caroppo et al. (31st May 2022) Authors: Martora, F.; Fabbrocini, G.; Nappa, P.; Marasca, C.; Patruno, C.; Scalvenzi, M.; Napolitano, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 9(2022) Page Start: e729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Reply to 'New‐onset cutaneous lichen planus triggered by COVID‐19 vaccination' by Merhy et al. (17th December 2021) Authors: Camela, E.; Guerrasio, G.; Patruno, C.; Scalvenzi, M.; Di Caprio, N.; Fabbrocini, G.; Napolitano, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 4(2022) Page Start: e249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Reply to Woltsche N. et al. Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single‐centre experience. (20th March 2019) Authors: Scalvenzi, M.; Costa, C.; Cappello, M.; Villani, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 4(2019) Page Start: e145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Second primary melanoma: incidence rate and risk factors. (19th May 2020) Authors: Villani, A.; Fabbrocini, G.; Costa, C.; Greco, V.; Scalvenzi, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 10(2020) Page Start: e623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗